Evaluation of the Veriton SPECT/CT System
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT04722185|
Recruitment Status : Recruiting
First Posted : January 25, 2021
Last Update Posted : January 25, 2021
|Condition or disease||Intervention/treatment||Phase|
|Focus of Study is Comparison of 2 Types of Gamma Cameras||Diagnostic Test: Veriton SPECT/CT||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||270 participants|
|Intervention Model:||Single Group Assignment|
|Intervention Model Description:||each patient will have 2 scans - one on a conventional system and one on the newer technology|
|Masking:||None (Open Label)|
|Official Title:||Evaluation of the Veriton SPECT/CT System|
|Actual Study Start Date :||January 20, 2021|
|Estimated Primary Completion Date :||January 1, 2022|
|Estimated Study Completion Date :||January 2, 2022|
Experimental: Evaluation of the Veriton SPECT/CT system
To determine if the Veriton system can achieve equal or better image quality than a standard SPECT/CT system.
Diagnostic Test: Veriton SPECT/CT
The Veriton system represents an FDA approved (510k cleared) new generation of SPECT/CT systems. It consists of 12 small gamma cameras arrayed in a circle around the patient, and is coupled to a 64-slice CT system.
- Image quality [ Time Frame: 1 year ]Assessment of relative image quality between the Veriton system and a conventional gamma camera as a function of the type of nuclear medicine exam.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04722185
|Contact: Kera Delaney||507-293-5660||Delaney.Kera@mayo.edu|
|Contact: Michael K O'Connor, PhDemail@example.com|
|United States, Minnesota|
|Mayo Clinic in Rochester||Recruiting|
|Rochester, Minnesota, United States, 55905|
|Principal Investigator: Michael K O'Connor|
|Principal Investigator:||Michael K O'Connor, PhD||Mayo Clinic|